ESC 365 - The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.

HFA Premium Access

The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.

Session: Poster Session 2 - Chronic Heart Failure – Diagnostic Methods

Topic: Biomarkers

Speaker: Professor D. Gruson (Brussels, BE)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Professor Damien Gruson

Cliniques Saint-Luc UCL, Brussels (Belgium)

1 follower

20 more presentations in this session

Soluble ST2/LVMI correlates with native T1 mapping value in 3T cardiac magnetic resonance in patients with dilated cardiomyopathy

Speaker: Associate Professor Y. Park (Yangsan, KR)

Dynamics of the stimulating growth factor sST2 and interleukin 33 in acute myocardial infarction

Speaker: Professor V. Larina (Moscow, RU)

BNP as the biomarker of diagnosis and prognosis in long-term mortality in a cohort with HFpEF and HFrEF in the south of Brazil

Speaker: Doctor E. Pitthan (Porto Alegre, BR)

Association between severity of heart failure and chemerin level

The effect of CPAP and oral appliances treatment on biomarkers in patients with heart failure and OSA

Speaker: Associate Professor I. Andreieva (Zaporizhzhia, UA)

Access the full session

Poster Session 2 - Chronic Heart Failure – Diagnostic Methods

Speakers: Professor D. Gruson, Associate Professor Y. Park, Professor V. Larina, Doctor E. Pitthan, Associate Professor I. Andreieva

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources